Anteotech Ltd
ASX:ADO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sany Renewable Energy Co Ltd
SSE:688349
|
CN |
|
J
|
JiShi Media Co Ltd
SSE:601929
|
CN |
|
Soma Textiles & Industries Ltd
NSE:SOMATEX
|
IN |
|
Jiangsu Leike Defense Technology Co Ltd
SZSE:002413
|
CN |
|
Colt CZ Group SE
OTC:CZGZF
|
CZ |
Anteotech Ltd
Intangible Assets
Anteotech Ltd
Intangible Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Anteotech Ltd
ASX:ADO
|
Intangible Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Genetic Technologies Ltd
ASX:GTG
|
Intangible Assets
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Proteomics International Laboratories Ltd
ASX:PIQ
|
Intangible Assets
AU$1k
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
T
|
Trajan Group Holdings Ltd
ASX:TRJ
|
Intangible Assets
AU$26.9m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
104%
|
CAGR 10-Years
N/A
|
|
|
Cryosite Ltd
ASX:CTE
|
Intangible Assets
AU$1.9m
|
CAGR 3-Years
470%
|
CAGR 5-Years
152%
|
CAGR 10-Years
16%
|
|
|
E
|
EZZ Life Science Holdings Ltd
ASX:EZZ
|
Intangible Assets
AU$28.1k
|
CAGR 3-Years
14%
|
CAGR 5-Years
88%
|
CAGR 10-Years
N/A
|
|
Anteotech Ltd
Glance View
AnteoTech Ltd. is a global nano-technology company, which develops, manufactures, and distributes products for the life sciences, clinical diagnostics and bio-separations markets. The company is headquartered in Eight Mile Plains, Queensland. The company went IPO on 2000-04-11. The firm is focused on the development and commercialization of its intellectual property of specialized surfaces used in the life sciences, diagnostics, energy and medical devices markets. The firm's products include AnteoCoat, AnteoBind and AnteoRelease, which are used in the energy, diagnostic and medical device markets. The firm's AnteoBind is an aqueous nanosized molecular glue (polymeric metal ions) used in a single-step process to facilitate multivalent coordination to bind carbohydrate polymers, antibodies, and proteins to synthetic substrates in assay development. The firm is also developing, SARS-CoV-2 Ag rapid test, which is a single-use, disposable, lateral flow test for the qualitative detection of SARS-CoV-2 nucleocapsid antigen in nasopharyngeal specimens collected from individuals who are suspected of COVID-19 infection.
